The Scientist III, Bioconjugation (ADC) Process Development, will have an opportunity to contribute to Exelixis’ Antibody Drug Conjugates (ADCs) technology platforms. The successful candidate will be responsible for the development of scale-able and robust downstream ADC processes and support technology transfer efforts, leading to clinical GMP manufacturing of ADCs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
1,001-5,000 employees